Cytokinetics inc
WebFeb 28, 2024 · SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response ... WebHeadquarters United States of America. Address ., 280 East Grand Avenue, South San Francisco, California, 94080. Website cytokinetics.com. Telephone 1 650 6243000. No of Employees 253. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange CYTK (NASD) Revenue (2024) $70.4M 26.2% (2024 vs 2024) EPS XXX.
Cytokinetics inc
Did you know?
WebMar 27, 2024 · empowering muscle empowering lives. Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people … Cytokinetics is a late-stage biopharmaceutical company focused on … Cytokinetics, Inc. does not by its reference above or distribution imply its … Cytokinetics is dedicated to helping underserved patient populations which … SEQUOIA-HCM (Safety, Efficacy, and Quantitative Understanding of … The key to muscle function is contraction. The principal functionality of muscle is … Heart failure affects 64 million people worldwide, hospitalizes more Americans … WebDec 13, 2024 · By Pratik Jain. Dec 13 (Reuters) - The U.S. Food and Drug Administration's panel of outside experts did not lend its support to Cytokinetics Inc's CYTK.O heart drug, citing insufficient data on ...
WebApr 7, 2024 · Annual Report to Security Holders (ars) April 07 2024 - 04:08PM. Edgar (US Regulatory) This regulatory filing also includes additional resources: edge20006209x502_ars.pdf. Cytokinetics (NASDAQ:CYTK) Historical Stock Chart. From Mar 2024 to Apr 2024. WebJul 19, 2024 · Shares of Cytokinetics (CYTK 7.16%) are up 48.4% as of 12:00 p.m. EDT on Monday. Investors were caught off guard by some encouraging results from a clinical trial with CK-274, a potential new ...
WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people … WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled ...
WebMar 31, 2024 · 8-K: CYTOKINETICS INC. Published: March 31, 2024 at 8:47 a.m. ET. The MarketWatch News Department was not involved in the creation of this content. (EDGAR Online via COMTEX ...
WebCytokinetics. Pharmaceuticals · California, United States · 253 Employees . Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. greens automotive greenfield ohioWebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have moved down 20.5% … greens auction manchester mdWebApr 10, 2024 · SOUTH SAN FRANCISCO, Apr 10, 2024 (GLOBE NEWSWIRE via COMTEX) -- SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated... greens auto sales and serviceWebCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential … fm 2021 face packWebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated (CYTK Quick Quote CYTK - Free Report) . Shares of the company have moved down 20.5% compared ... fm 2021 knap tacticsWebDec 9, 2024 · Cytokinetics continues its over 20-year history of pioneering innovation in muscle biology and related pharmacology focused to diseases of muscle dysfunction and conditions of muscle weakness. greens automotive rowlett txWebAbout The Company. Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing potential treatments for debilitating diseases in which muscle performance is compromised. As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug ... greens automotive